WASHINGTON – While the broader HME industry is cheering the passage of the 21st Century Cures Act, home infusion is facing reimbursement cuts—effective almost immediately.
FLINT, Mich. – Diplomat Pharmacy has launched Diplomat Specialty Infusion Group, a new brand to unite five subsidiaries: American Homecare Federation, At-Home IV Infusion Professional, BioRx, MedPro Rx and XAS Infusion Suites.
MedTrakRx, a pharmacy benefit manager, has selected ARJ Infusion Services, a specialty pharmacy, to provide home infusion therapies to patients with complex, rare and chronic conditions.
Daniel Greenleaf is in a familiar position. The new president and CEO of BioScrip is tasked with turning around an underperforming home infusion company, which he did with both Coram and, more recently, with Home Solutions.
ALEXANDRIA, Va. – A recent Office of Inspector General report on payment for Part B DME infusion drugs is far too narrow to be the basis for new policy, according to the National Home Infusion Association.
PharMerica Corp., a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, has announced that David Froesel, executive vice president, CFO and treasurer, intends to retire.
ORLANDO, Fla. – Close monitoring of hemophilia patients ensures bleed rate stays low and the patients can be managed with less factor VIII, according to a study by Option Care being presented at the World Federation of Hemophilia 2016 World Congress meeting today.
DENVER – BioScrip, a provider of infusion and homecare management solutions, has entered into an agreement to buy the business of HS Infusion Holdings.
